Grant: Master's Award: Canada Graduate Scholarships
University of Calgary
$17,500.00
Exosome Mediated Reprogramming of fibroblast cells to hepatocytes for pharmacological study
EF 2019-20
Résumé
"Annually, adverse drug reactions account for the deaths of up to 22,000 Canadians and are associated with a cost of up to $18 billion. The prediction of adverse drug reactions can be greatly facilitated through drug screening via hepatocyte-like cells (HLCs). Thus, an efficient method for the generation of HLCs is necessary for drug screening. I am proposing the use of eXosome-Mediated cellular Reprogramming (XMR) to trans-differentiate human fibroblast cells into HLCs, facilitating the study of patient drug metabolism. Exosomes, small membrane-bound vesicles that engage in the delivery of genetic material between cells, have successfully been used in the Rancourt lab to trans-differentiate fibroblast cells to neuronal cells. This process simplifies the current methodology for cellular reprogramming, which relies on a pluripotent intermediate state between both fibroblast and target cell type. In trans-differentiation, fibroblast cells can be efficiently differentiated to target cell types without having to generate induced Pluripotent Stem Cells (iPSCs). The benefit of using exosomes in this process is two-fold when we consider that their use does not involve the integration of genetic material to target cells, thus significantly reducing the probability that these cells will develop tumours upon implantation. Therefore, this project would allow the safe and efficient generation of high volumes of HLCs for drug screening, and potentially clinical application and transplantation."
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
428859
Name
Heale Kali A
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exosome Mediated Reprogramming of fibroblast cells to hepatocytes for pharmacological study
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adverse Drug Reactions; Exosomes; Hepatocyte-Like Cells; Induced Pluripotent Stem Cells (Ipscs); Trans-Differentiation
Abstract
"Annually, adverse drug reactions account for the deaths of up to 22,000 Canadians and are associated with a cost of up to $18 billion. The prediction of adverse drug reactions can be greatly facilitated through drug screening via hepatocyte-like cells (HLCs). Thus, an efficient method for the generation of HLCs is necessary for drug screening. I am proposing the use of eXosome-Mediated cellular Reprogramming (XMR) to trans-differentiate human fibroblast cells into HLCs, facilitating the study of patient drug metabolism. Exosomes, small membrane-bound vesicles that engage in the delivery of genetic material between cells, have successfully been used in the Rancourt lab to trans-differentiate fibroblast cells to neuronal cells. This process simplifies the current methodology for cellular reprogramming, which relies on a pluripotent intermediate state between both fibroblast and target cell type. In trans-differentiation, fibroblast cells can be efficiently differentiated to target cell types without having to generate induced Pluripotent Stem Cells (iPSCs). The benefit of using exosomes in this process is two-fold when we consider that their use does not involve the integration of genetic material to target cells, thus significantly reducing the probability that these cells will develop tumours upon implantation. Therefore, this project would allow the safe and efficient generation of high volumes of HLCs for drug screening, and potentially clinical application and transplantation."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Heale, Kali A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~